BioSpecifics Technologies
Biopharmaceutical company that has developed injectable collagenase for twelve clinical indications to date.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD835m (Public information from Oct 2020)
Hempstead New York (HQ)
Authorizing premium user...